Australia's most trusted source of pharma news
Friday, 21 September 2018
Lost Your Access?
More govt PBS cases in wings
Reserved judgements likely to determine if actions go ahead.
New migraine drug on horizon
Teva files Aimovig competitor with TGA.
AZ breaks Servier dream run
Ousts long-time winner to take out 2018 GPs' choice award.
Pfizer award dominance ends
Nine pharmacos took home PRIME gongs last night.
PBAC realigns biosim process
Declares an end to parallel processing for biosims.
Swan song for Sanofi
Praise and criticism from former Treasurer.
CSL reveals boss's pay
Take-home marginally lower than last year but still in millions.
Hunt gives Roche a boost
Announces $48m in PBS listings for October.
Sanofi announces restructure
Creating new business units from old.
Hurricane hits pharma plants
Pfizer, Novartis, MSD, Novo suspend manufacture.
ACCC ticks generics merger
Green light for Apotex/Arrow build potential market leader.
Speedy blood drug targets NBA
Roche's Hemlibra now looking for fast reimbursement.
Wilson would pilot NMP review
But not while still in PBAC chair.
Pharma tax claims flawed: ATO
Aust & NZ tax authorities reject anti-pharma Oxfam report.
Sydney pharma scores TGA win
Biocelect follows GSK in getting malaria pill to market.
AZ blood drug wins over FDA
Green light in hairy cell leukaemia.
It really is about trust
MA appears to be adopting the ostrich approach to trust deficit.
New psoriasis drug ticked
Already recommended by PBAC.
Events & Conferences
© 2003 - 2018 Lush Media
Pharma in Focus
Jolly Good Design